Alcon Reiterates Value of STAAR Merger Proposal in Investor Discussion Materials

GENEVA, Switzerland—Alcon (SIX/NYSE: ALC), a global leader in eyecare, announced on November 4 that it has filed an investor presentation in support of its proposed acquisition of STAAR Surgical Company (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (SEC). First announced in August, the transaction represents a total equity value of approximately $1.5 billion, as reported in VMAIL at that time. In the November 4 announcement, Alcon said that it plans to initiate outreach to STAAR stockholders, and that the presentation highlights key considerations for these discussions, including the following: